PL4322973T3 - Produkt z jaja po hiperimmunizacji do leczenia lub zapobiegania alkoholowej chorobie wątroby i chorobie przeszczep przeciwko gospodarzowi - Google Patents
Produkt z jaja po hiperimmunizacji do leczenia lub zapobiegania alkoholowej chorobie wątroby i chorobie przeszczep przeciwko gospodarzowiInfo
- Publication number
- PL4322973T3 PL4322973T3 PL22726551.9T PL22726551T PL4322973T3 PL 4322973 T3 PL4322973 T3 PL 4322973T3 PL 22726551 T PL22726551 T PL 22726551T PL 4322973 T3 PL4322973 T3 PL 4322973T3
- Authority
- PL
- Poland
- Prior art keywords
- verse
- grafts
- prevention
- alcohol
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163175603P | 2021-04-16 | 2021-04-16 | |
| PCT/US2022/024946 WO2022221616A1 (en) | 2021-04-16 | 2022-04-15 | Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft-versus-host disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4322973T3 true PL4322973T3 (pl) | 2025-08-18 |
Family
ID=81926046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22726551.9T PL4322973T3 (pl) | 2021-04-16 | 2022-04-15 | Produkt z jaja po hiperimmunizacji do leczenia lub zapobiegania alkoholowej chorobie wątroby i chorobie przeszczep przeciwko gospodarzowi |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12435125B2 (pl) |
| EP (1) | EP4322973B1 (pl) |
| JP (1) | JP2024522404A (pl) |
| KR (1) | KR20230172005A (pl) |
| CN (1) | CN117440818A (pl) |
| AU (1) | AU2022258701A1 (pl) |
| BR (1) | BR112023021345A2 (pl) |
| CA (1) | CA3215464A1 (pl) |
| CL (1) | CL2023003066A1 (pl) |
| CO (1) | CO2023014297A2 (pl) |
| ES (1) | ES3040111T3 (pl) |
| HU (1) | HUE072848T2 (pl) |
| IL (1) | IL307440B2 (pl) |
| MX (1) | MX2023012232A (pl) |
| PL (1) | PL4322973T3 (pl) |
| WO (1) | WO2022221616A1 (pl) |
| ZA (1) | ZA202310022B (pl) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748018A (en) | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
| US7105158B1 (en) | 1992-11-16 | 2006-09-12 | The Corporation Of Mercer University | Methods of administering microencapsulated materials for immune modulated diseases |
| US5367054A (en) | 1993-04-12 | 1994-11-22 | Stolle Research & Development Corp. | Large-scale purification of egg immunoglobulin |
| US5772999A (en) | 1996-07-30 | 1998-06-30 | Dcv Biologics, L.P. | Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
| AU729502B2 (en) * | 1996-10-02 | 2001-02-01 | Ovimmune, Inc. | Oral administration of chicken yolk antibodies to treat disease |
| US6803035B2 (en) | 1998-05-08 | 2004-10-12 | Arkion Life Sciences | Anti-diarrheal and method for using the same |
| US6706267B1 (en) | 1999-09-14 | 2004-03-16 | Arkion Life Sciences Llc | Glucosamine and egg for reducing inflammation |
| EP1633378A2 (en) * | 2003-06-13 | 2006-03-15 | N.V. Nutricia | Pediocin-producing pediococci |
| EP3461840A1 (en) * | 2009-04-27 | 2019-04-03 | Immuron Limited | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of non alcoholic steatohepatitis |
| ES2742734T3 (es) | 2010-11-23 | 2020-02-17 | Pantheryx Inc | Composiciones y procedimientos para el tratamiento en aplicaciones clínicas de espectro general, no diferenciadas o mixtas |
| US10632158B2 (en) | 2016-06-23 | 2020-04-28 | IgY Nutrition | Use of a hyperimmune egg product to prevent and treat dysbiosis |
-
2022
- 2022-04-15 IL IL307440A patent/IL307440B2/en unknown
- 2022-04-15 US US18/555,338 patent/US12435125B2/en active Active
- 2022-04-15 CN CN202280036488.6A patent/CN117440818A/zh active Pending
- 2022-04-15 WO PCT/US2022/024946 patent/WO2022221616A1/en not_active Ceased
- 2022-04-15 PL PL22726551.9T patent/PL4322973T3/pl unknown
- 2022-04-15 JP JP2023563268A patent/JP2024522404A/ja active Pending
- 2022-04-15 MX MX2023012232A patent/MX2023012232A/es unknown
- 2022-04-15 CA CA3215464A patent/CA3215464A1/en active Pending
- 2022-04-15 BR BR112023021345A patent/BR112023021345A2/pt active Search and Examination
- 2022-04-15 AU AU2022258701A patent/AU2022258701A1/en active Pending
- 2022-04-15 HU HUE22726551A patent/HUE072848T2/hu unknown
- 2022-04-15 KR KR1020237039461A patent/KR20230172005A/ko active Pending
- 2022-04-15 EP EP22726551.9A patent/EP4322973B1/en active Active
- 2022-04-15 ES ES22726551T patent/ES3040111T3/es active Active
-
2023
- 2023-10-13 CL CL2023003066A patent/CL2023003066A1/es unknown
- 2023-10-25 CO CONC2023/0014297A patent/CO2023014297A2/es unknown
- 2023-10-26 ZA ZA2023/10022A patent/ZA202310022B/en unknown
-
2025
- 2025-07-16 US US19/270,685 patent/US20250340620A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL307440A (en) | 2023-12-01 |
| CL2023003066A1 (es) | 2024-05-03 |
| CA3215464A1 (en) | 2022-10-20 |
| HUE072848T2 (hu) | 2025-12-28 |
| EP4322973C0 (en) | 2025-06-04 |
| CO2023014297A2 (es) | 2023-10-30 |
| EP4322973B1 (en) | 2025-06-04 |
| JP2024522404A (ja) | 2024-06-20 |
| IL307440B2 (en) | 2025-12-01 |
| AU2022258701A1 (en) | 2023-10-26 |
| CN117440818A (zh) | 2024-01-23 |
| IL307440B1 (en) | 2025-08-01 |
| ES3040111T3 (en) | 2025-10-28 |
| WO2022221616A1 (en) | 2022-10-20 |
| ZA202310022B (en) | 2025-03-26 |
| US20240199723A1 (en) | 2024-06-20 |
| BR112023021345A2 (pt) | 2023-12-19 |
| MX2023012232A (es) | 2023-11-22 |
| KR20230172005A (ko) | 2023-12-21 |
| US12435125B2 (en) | 2025-10-07 |
| NZ804299A (en) | 2025-07-25 |
| US20250340620A1 (en) | 2025-11-06 |
| EP4322973A1 (en) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4044940A4 (en) | Patient-specific instrumentation and methods for ankle arthroplasty | |
| EP3672639A4 (en) | COMBINATION PRODUCT OF A BCL-2 INHIBITOR OR A DUAL BCL-2 / BCL-XL INHIBITOR AND A BTK INHIBITOR AND ITS USE IN THE PREVENTION AND / OR TREATMENT OF DISEASES | |
| PL3810128T3 (pl) | Kompozycje do leczenia i/lub zapobiegania chorobom związanym z agregacją białek | |
| EP3672594A4 (en) | COMBINATION PRODUCT OF BCL -2 INHIBITOR AND MDM2 INHIBITOR, AND USE OF THE LATTER IN THE PREVENTION AND / OR TREATMENT OF DISEASES | |
| EP3672595A4 (en) | COMBINATION PRODUCT OF A BCL-2 INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND ASSOCIATED USE IN THE PREVENTION AND / OR TREATMENT OF DISEASES | |
| EP4373939A4 (en) | Genome editing compositions and treatment methods for chronic granulomatous disease | |
| HRP20260171T1 (hr) | Peptidi za liječenje i prevenciju bolesti nealkoholne masne jetre | |
| EP3781158A4 (en) | Compositions for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | |
| EP3728279A4 (en) | GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISORDERS | |
| EP4142770C0 (en) | SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | |
| DK3484304T3 (da) | Fremgangsmåde til fremstilling af koncentrerede eller tørrede syregelerbare valleproteinaggregater og relaterede sammensætninger og fødevareprodukter | |
| EP3866852A4 (en) | COMPOSITIONS AND METHODS OF TREATING HEPATIC DISEASES | |
| EP3569238A4 (en) | COMPOSITION FOR TREATING NEWBORN EHI | |
| EP4643689A4 (en) | AEROSOL GENERATION SUBSTRATE AND AEROSOL GENERATION PRODUCT | |
| EP3817749A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | |
| EP4249398C0 (en) | PACKAGING FOR THE PRESERVATION OF RESPIRATORY PRODUCTS AND ASSOCIATED PROCESS | |
| EP3960243A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF TREATMENT-RESISTANT CANCER | |
| EP3638277A4 (en) | COMPOSITIONS AND PROCEDURES FOR INHIBITING BETA SECRETASE | |
| CO2022002627A2 (es) | Composiciones biofarmacéuticas y procedimientos conexos | |
| EP3908267C0 (fr) | Produit pour le traitement de dysbioses | |
| EP3610879A4 (en) | COMPOSITION OF TREATMENT AND / OR PREVENTION OF ALZHEIMER'S DISEASE | |
| IL312885A (en) | Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma | |
| EP4000629C0 (en) | COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSE (NAFLD) | |
| EP4262848A4 (en) | DIPHENHYDRAMINE AND LACTOFERRIN FOR THE PREVENTION AND TREATMENT OF COVID-19 | |
| IL285828A (en) | Compounds for treating and preventing net associated complications |